SCHEMBL1847356

SCHEMBL1847356

CCC(C)N(N)c1ncc(C(N)=O)c(-c2cc(C)cc(C)c2)n1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SYK P43405 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1848248 0.89 SYK (0.43) SYK
SCHEMBL1848308 0.74 SYK (0.60) SYK
SCHEMBL1848307 0.74 SYK (0.60) SYK
SCHEMBL14320333 0.73 NNMT (0.43) SYK
SCHEMBL1849097 0.73 SYK (0.64) SYK
SCHEMBL1848081 0.71 SYK (0.58) SYK
SCHEMBL1355443 0.71 SYK (0.71) SYK
SCHEMBL1355440 0.71 SYK (0.71) SYK
SCHEMBL1849058 0.70 SYK (0.57) SYK
SCHEMBL1849063 0.70 SYK (0.57) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323993-A2 2,6-DIAMINO- PYRIMIDIN- 5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS Portola Pharmaceuticals, Inc. (US) 2011-05-25 EP disclosed
WO-2009136995-A2 INHIBITORS OF SYK PROTEIN KINASE PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-12 WO disclosed